| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| gL(L) | 1,421 | 64.9% | -1.17 | 631 | 84.0% |
| PLP(L) | 447 | 20.4% | -7.80 | 2 | 0.3% |
| CentralBrain-unspecified | 153 | 7.0% | -1.40 | 58 | 7.7% |
| PED(L) | 41 | 1.9% | -1.11 | 19 | 2.5% |
| CRE(L) | 24 | 1.1% | -0.58 | 16 | 2.1% |
| SCL(L) | 28 | 1.3% | -inf | 0 | 0.0% |
| a'L(L) | 14 | 0.6% | -0.35 | 11 | 1.5% |
| SIP(L) | 14 | 0.6% | -0.81 | 8 | 1.1% |
| Optic-unspecified(L) | 14 | 0.6% | -inf | 0 | 0.0% |
| SLP(L) | 11 | 0.5% | -inf | 0 | 0.0% |
| b'L(L) | 6 | 0.3% | -1.00 | 3 | 0.4% |
| CA(L) | 7 | 0.3% | -inf | 0 | 0.0% |
| ICL(L) | 3 | 0.1% | -inf | 0 | 0.0% |
| RUB(L) | 3 | 0.1% | -inf | 0 | 0.0% |
| LAL(L) | 1 | 0.0% | 1.00 | 2 | 0.3% |
| bL(L) | 2 | 0.1% | -1.00 | 1 | 0.1% |
| LH(L) | 2 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KCg-s1 | % In | CV |
|---|---|---|---|---|---|
| KCg-m (L) | 374 | DA | 635 | 31.0% | 0.6 |
| KCg-d (L) | 87 | DA | 316 | 15.4% | 0.7 |
| APL (L) | 1 | GABA | 160 | 7.8% | 0.0 |
| aMe12 (L) | 4 | ACh | 135 | 6.6% | 0.3 |
| DPM (L) | 1 | DA | 99 | 4.8% | 0.0 |
| MeVPLo2 (R) | 7 | ACh | 65 | 3.2% | 0.5 |
| PAM08 (L) | 16 | DA | 58 | 2.8% | 0.8 |
| aMe6a (L) | 1 | ACh | 47 | 2.3% | 0.0 |
| KCg-s2 (L) | 1 | DA | 31 | 1.5% | 0.0 |
| MeVPLo2 (L) | 6 | ACh | 30 | 1.5% | 0.5 |
| PAM07 (L) | 6 | DA | 29 | 1.4% | 0.6 |
| aMe12 (R) | 2 | ACh | 28 | 1.4% | 0.1 |
| MBON05 (R) | 1 | Glu | 24 | 1.2% | 0.0 |
| PAM01 (L) | 12 | DA | 21 | 1.0% | 0.6 |
| MeVP43 (L) | 1 | ACh | 19 | 0.9% | 0.0 |
| PAM08 (R) | 10 | DA | 19 | 0.9% | 0.5 |
| LoVP38 (L) | 2 | Glu | 18 | 0.9% | 0.2 |
| PPL103 (R) | 1 | DA | 14 | 0.7% | 0.0 |
| aMe26 (L) | 3 | ACh | 14 | 0.7% | 0.5 |
| PAM12 (L) | 9 | DA | 14 | 0.7% | 0.4 |
| LHPV6m1 (L) | 1 | Glu | 13 | 0.6% | 0.0 |
| KCg-s3 (L) | 1 | DA | 12 | 0.6% | 0.0 |
| PPL103 (L) | 1 | DA | 11 | 0.5% | 0.0 |
| KCg-s4 (L) | 1 | DA | 10 | 0.5% | 0.0 |
| KCg (L) | 1 | DA | 10 | 0.5% | 0.0 |
| PAM12 (R) | 6 | DA | 9 | 0.4% | 0.5 |
| MeVP41 (L) | 1 | ACh | 8 | 0.4% | 0.0 |
| PAM01 (R) | 6 | DA | 8 | 0.4% | 0.6 |
| PPL101 (L) | 1 | DA | 7 | 0.3% | 0.0 |
| CL063 (L) | 1 | GABA | 7 | 0.3% | 0.0 |
| PPL101 (R) | 1 | DA | 6 | 0.3% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 6 | 0.3% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 6 | 0.3% | 0.0 |
| KCa'b'-ap2 (L) | 6 | DA | 6 | 0.3% | 0.0 |
| CB3676 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| aMe22 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| aMe10 (R) | 2 | ACh | 5 | 0.2% | 0.6 |
| aMe26 (R) | 3 | ACh | 5 | 0.2% | 0.6 |
| VP1m+VP2_lvPN2 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| LoVP37 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| aMe30 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| LT43 (L) | 2 | GABA | 4 | 0.2% | 0.0 |
| PAM07 (R) | 2 | DA | 4 | 0.2% | 0.0 |
| aMe5 (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| LPT51 (L) | 2 | Glu | 4 | 0.2% | 0.0 |
| PLP080 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| MBON16 (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| PPL104 (L) | 1 | DA | 3 | 0.1% | 0.0 |
| VP1m+VP5_ilPN (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| FR1 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| MBON09 (L) | 2 | GABA | 3 | 0.1% | 0.3 |
| KCa'b'-ap1 (L) | 3 | DA | 3 | 0.1% | 0.0 |
| PLP129 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP14 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| PAM02 (L) | 1 | DA | 2 | 0.1% | 0.0 |
| LHPV4g2 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| CL064 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| PPL104 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| MeVP20 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| PLP231 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| PPL102 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| DN1a (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| LoVP96 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 2 | 0.1% | 0.0 |
| MeVP49 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| LPT53 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 2 | 0.1% | 0.0 |
| PAM06 (L) | 2 | DA | 2 | 0.1% | 0.0 |
| SLP461 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB1976 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CB0951 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| DNp27 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PAM05 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| CRE055 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| PLP185 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| PLP131 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| SLP456 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| KCab-s (L) | 1 | DA | 1 | 0.0% | 0.0 |
| SIP042_b (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CB3001 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu4a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHPV6h1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| M_lvPNm25 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LAL030_b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP410 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| OCG02c (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHPD2a4_b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP086 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| SMP245 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB3874 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP345 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE083 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL134 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| FB4P_c (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MB-C1 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVP21 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe9 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SLP380 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| AVLP562 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON32 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC22 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON21 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LoVC18 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| MBON11 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| CRE075 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 1 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns KCg-s1 | % Out | CV |
|---|---|---|---|---|---|
| KCg-m (L) | 438 | DA | 829 | 33.2% | 0.6 |
| KCg-d (L) | 88 | DA | 358 | 14.3% | 0.6 |
| MBON09 (L) | 2 | GABA | 160 | 6.4% | 0.0 |
| APL (L) | 1 | GABA | 152 | 6.1% | 0.0 |
| MBON01 (L) | 1 | Glu | 85 | 3.4% | 0.0 |
| PAM08 (L) | 23 | DA | 79 | 3.2% | 0.7 |
| MBON05 (R) | 1 | Glu | 78 | 3.1% | 0.0 |
| PAM07 (L) | 7 | DA | 71 | 2.8% | 0.4 |
| MBON32 (L) | 1 | GABA | 57 | 2.3% | 0.0 |
| MBON11 (L) | 1 | GABA | 57 | 2.3% | 0.0 |
| DPM (L) | 1 | DA | 50 | 2.0% | 0.0 |
| PAM01 (L) | 19 | DA | 49 | 2.0% | 0.7 |
| KCg-s2 (L) | 1 | DA | 34 | 1.4% | 0.0 |
| MBON30 (L) | 1 | Glu | 28 | 1.1% | 0.0 |
| PAM08 (R) | 16 | DA | 27 | 1.1% | 0.9 |
| MBON35 (L) | 1 | ACh | 22 | 0.9% | 0.0 |
| MBON27 (L) | 1 | ACh | 20 | 0.8% | 0.0 |
| MBON33 (L) | 1 | ACh | 20 | 0.8% | 0.0 |
| PAM01 (R) | 10 | DA | 20 | 0.8% | 0.5 |
| KCg (L) | 1 | DA | 19 | 0.8% | 0.0 |
| MBON20 (L) | 1 | GABA | 18 | 0.7% | 0.0 |
| PPL103 (R) | 1 | DA | 15 | 0.6% | 0.0 |
| PAM12 (L) | 8 | DA | 14 | 0.6% | 0.4 |
| PPL103 (L) | 1 | DA | 13 | 0.5% | 0.0 |
| PPL101 (R) | 1 | DA | 13 | 0.5% | 0.0 |
| KCg-s3 (L) | 1 | DA | 12 | 0.5% | 0.0 |
| MBON21 (L) | 1 | ACh | 12 | 0.5% | 0.0 |
| MBON12 (L) | 2 | ACh | 12 | 0.5% | 0.5 |
| MBON16 (L) | 1 | ACh | 10 | 0.4% | 0.0 |
| MBON29 (L) | 1 | ACh | 8 | 0.3% | 0.0 |
| MBON04 (R) | 1 | Glu | 7 | 0.3% | 0.0 |
| KCg-s4 (L) | 1 | DA | 7 | 0.3% | 0.0 |
| PAM12 (R) | 6 | DA | 7 | 0.3% | 0.3 |
| KCa'b'-ap1 (L) | 6 | DA | 7 | 0.3% | 0.3 |
| PPL102 (R) | 1 | DA | 6 | 0.2% | 0.0 |
| MBON05 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| PPL104 (L) | 1 | DA | 5 | 0.2% | 0.0 |
| MBON28 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| PPL101 (L) | 1 | DA | 5 | 0.2% | 0.0 |
| KCa'b'-ap2 (L) | 4 | DA | 5 | 0.2% | 0.3 |
| CRE022 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| MBON29 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| OA-VPM4 (R) | 1 | OA | 4 | 0.2% | 0.0 |
| PPL104 (R) | 1 | DA | 3 | 0.1% | 0.0 |
| LAL100 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| CRE200m (R) | 2 | Glu | 3 | 0.1% | 0.3 |
| CRE067 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| SMP376 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MBON26 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| mALD3 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| PPL105 (L) | 1 | DA | 2 | 0.1% | 0.0 |
| MBON25 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| OA-VPM3 (L) | 1 | OA | 2 | 0.1% | 0.0 |
| PAM07 (R) | 1 | DA | 2 | 0.1% | 0.0 |
| SMP179 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MBON22 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| OA-VPM3 (R) | 1 | OA | 2 | 0.1% | 0.0 |
| PAM04 (L) | 2 | DA | 2 | 0.1% | 0.0 |
| PAM02 (L) | 2 | DA | 2 | 0.1% | 0.0 |
| FB4R (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MBON04 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SMP190 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL303 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| SMP053 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON30 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MBON17-like (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP030 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PAM15 (R) | 1 | DA | 1 | 0.0% | 0.0 |
| CB1197 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| SMP450 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CRE081 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE068 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP377 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON25-like (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| ATL039 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP042_c (L) | 1 | unc | 1 | 0.0% | 0.0 |
| SMP573 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SLP451 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP076 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| LH008m (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON10 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| FB4P_a (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| PAM10 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| MBON17 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE080_a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE044 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| CRE070 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE024 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP152 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE080_b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHAV3m1 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| PPL202 (L) | 1 | DA | 1 | 0.0% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP577 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| AVLP562 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MBON22 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CRE100 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| WEDPN4 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| LAL159 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| APL (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| CRE023 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.0% | 0.0 |
